Gastrointestinal cancer: CDX2: prognostic marker for high-risk colon cancer

Nat Rev Clin Oncol. 2016 Mar;13(3):134-5. doi: 10.1038/nrclinonc.2016.18. Epub 2016 Feb 16.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Colonic Neoplasms / genetics*
  • Female
  • Gene Expression*
  • Homeodomain Proteins / metabolism*
  • Humans
  • Male

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Homeodomain Proteins